
Dysbiosis of the Salivary Microbiome is Associated with Hypertension and Correlated with Metabolic Syndrome Biomarkers
Author(s) -
Muhammad Sohail,
Lars O. Hedin,
Maha Al-Asmakh
Publication year - 2021
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s325073
Subject(s) - firmicutes , prevotella , dysbiosis , microbiome , medicine , oral microbiome , dyslipidemia , saliva , bacteroidetes , metabolic syndrome , diabetes mellitus , veillonella , endocrinology , physiology , obesity , biology , bioinformatics , streptococcus , genetics , bacteria , 16s ribosomal rna
Hypertension (HT) is an idiopathic disease with severe complications and a high incidence of global mortality. Although the disease shares characteristic features with diabetes and obesity, the complex interplay of endogenous and environmental factors is not well characterized. The oral microbiome has recently been studied to better understand the role of commensal microorganisms in metabolic disorders, including HT, although its role in disease etiology is unclear.